All Pandemics are 100 years old and innovation is older – Elexes
Elexes Medical Consulting

“O lost, and by the wind grieved, ghost, come back again.” as rightly said by Thomas Wolfe; the globe faces a deadly pandemic every 100 years. 

COVID this year has been very difficult for everyone around the world, with people not being able to move around, some families being apart in different locations for a long period of time, kids staying at home when they should not be restricted from going out, and healthcare professionals working day and night to meet the ever increasing burden on the healthcare system. But, innovation in these trying times continues to make a difference! 

It is innovation that has helped us better manage the situation by allowing testing to facilitate timely quarantine and treatment. Without the drugs, devices and In-Vitro-Diagnostics in place, it is unimaginable on what the situation might have been. Elexes is doing its bit by supporting companies to get through the FDA EUA and other expedited approvals. Please do not hesitate to reach out to jennifer@elexes.com if you are interested in learning more. Kudos to Fresenius, Baxter, Omnipathology, and the many out there making a difference! 

Picture credits: Freepik

Leave a Reply

You may also like

Medical Devices

Breakthrough vs. STeP, which one is more apt for your medical device?

Both STeP and Breakthrough Device Program comprises 2 Phases.  In the first Phase, sponsors formally request inclus

Medical Devices

Clinical trials in South Africa – worldwide accepted data

Clinical trials being a resource, cost, and time extensive process, identifying the right location for a clinical trial

Medical Devices

RUO – A Market Opportunity for IVD companies

Getting an IVD product to the market is a cumbersome task and takes several months to over a year to finally get everyth

Medical Devices

Official Number is now 15 – MDD to MDR + IVDD to IVDR Planning

Everyone knows that the advent of MDR was postponed, and the new regulation shall be in full force from May 26, 2021. As